
Asukamycin
CAS: 61116-33-4
Ref. 3D-LCA11633
1mg | 856.00 € | ||
5mg | 2,275.00 € | ||
10mg | 3,639.00 € | ||
25mg | 6,823.00 € | ||
50mg | 10,916.00 € |
Product Information
- 2,4,6-Heptatrienamide, 7-cyclohexyl-N-[5-hydroxy-5-[7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-, [1S-[1α,3(2E,4E,6E),5β,5(1E,3E,5E),6α]]-
- (2E,4E,6E)-7-Cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4,6-heptatrienamide
- 2,4,6-Heptatrienamide, 7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrienyl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-, (2E,4E,6E)-
- 7-Oxabicyclo[4.1.0]heptane, 2,4,6-heptatrienamide deriv.
- 2,4,6-Heptatrienamide, 7-cyclohexyl-N-[(1S,5S,6R)-5-hydroxy-5-[(1E,3E,5E)-7-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-7-oxo-1,3,5-heptatrien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-, (2E,4E,6E)-
Asukamycin is a methyltransferase inhibitor that binds to the active site of enzymes such as fatty acid synthase, acetyl-coenzyme A carboxylase and hydroxylase. It has been shown to be effective against infectious diseases such as malaria and tuberculosis. Asukamycin is also known to inhibit the growth of cancer cells in vitro and in vivo by inhibiting transcriptional regulation. In addition, it inhibits the production of monoclonal antibodies that are important for immune response. Finally, this compound can bind to human macrophages and prevent their activation by acetate extract from Escherichia coli or polyene from Candida albicans.
Chemical properties
Technical inquiry about: 3D-LCA11633 Asukamycin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.